RT @CochraneHeart: Our second recent publication is review 'Beta-blockers in patients without heart failure after myocardial infarction': h…
RT @FarmaMadridAP: (Cochrane) Betabloqueantes en pacientes sin insuficiencia cardíaca tras un infarto de miocardio. https://t.co/uuTRES4YQG
RT @rincondesisifo: (Cochrane) Seguridad y eficacia de los betabloqueantes en pac postIAM sin ICC https://t.co/JEaTv8NU9U https://t.co/odwo…
RT @FarmaMadridAP: (Cochrane) Betabloqueantes en pacientes sin insuficiencia cardíaca tras un infarto de miocardio. https://t.co/uuTRES4YQG
Los betabloqueantes probablemente reducen los riesgos de mortalidad por todas las causas y de reinfarto de miocardio en pacientes menores de 75 años sin insuficiencia cardíaca tras un infarto agudo de miocardio
(Cochrane) Seguridad y eficacia de los betabloqueantes en pac postIAM sin ICC https://t.co/JEaTv8NU9U https://t.co/odwowH1dtY
(Cochrane) Betabloqueantes en pacientes sin insuficiencia cardíaca tras un infarto de miocardio. https://t.co/uuTRES4YQG
RT @CochraneHeart: Our second recent publication is review 'Beta-blockers in patients without heart failure after myocardial infarction': h…
RT @CochraneHeart: Our second recent publication is review 'Beta-blockers in patients without heart failure after myocardial infarction': h…
RT @CochraneUK: What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial infarct…
RT @CochraneUK: What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial infarct…
What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial infarction? https://t.co/GfRpuGAnNL New @CochraneHeart systematic review looks at the evidence from 25 trials randomising 22,423 partici
RT @CochraneLibrary: What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial in…
RT @CochraneLibrary: What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial in…
What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial infarction? https://t.co/onpJ6K5xSV New @CochraneHeart systematic review looks at the evidence from 25 trials randomising 22,423 partic
RT @cochrane_nz: What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial infarc…
RT @cochrane_nz: What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial infarc…
RT @cochrane_nz: What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial infarc…
What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial infarction? https://t.co/yc2CE8740M New @CochraneHeart systematic review looks at the evidence from 25 trials randomising 22,423 partici
¿Cuáles son los efectos beneficiosos y perjudiciales de los beta-bloqueadores vs. placebo o no intervención en fase no aguda del infarto de miocardio? https://t.co/hP8RkHUc5z La nueva revisión de @CochraneHeart analiza 25 ensayos con 22,423 participantes
Skal patienter have betablokker efter et myokardieinfarkt uden efterfølgende hjertesvigt? Dette review taler for det, men dog ulempe at studie ikke omfatter patienter over 75 år https://t.co/Urajc6eYRZ #dklæger #kardiologi #geriatri #studier
RT @kevinmb01: Benefits and harms of beta-blockers versus placebo or no intervention in the non-acute phase of a myocardial infarction http…
Beta‐blockers in patients without heart failure after myocardial infarction - Safi, S - 2021 | Cochrane Library https://t.co/NExL6YOmpu
RT @CochraneLibrary: What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial in…
RT @CochraneLibrary: What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial in…
RT @CochraneHeart: Our second recent publication is review 'Beta-blockers in patients without heart failure after myocardial infarction': h…
Our second recent publication is review 'Beta-blockers in patients without heart failure after myocardial infarction': https://t.co/9KZJxD1cc2
#BibliotecaCochrane #Cardiología Si requieres el texto completo, puedes solicitarlo al #CEIDS del #HGMEL.
RT @CochraneLibrary: What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial in…
What are the benefits & harms of beta‐blockers vs placebo or no intervention in the non‐acute phase of a myocardial infarction? https://t.co/onpJ6Kn9hv New @CochraneHeart systematic review looks at the evidence from 25 trials randomising 22,423 partici